Medication-Overuse Headache (Triptan or Analgesic Overuse): What to Do When Counselling Alone Did Not Restore an Episodic Pattern
Clinical Scenario
This protocol applies to patients with medication-overuse headache driven by overuse of triptans, simple (non-opioid) analgesics, or ergotamine — without major psychiatric comorbidity, and without overuse of opioids, barbiturates, or tranquilizers.
Previous step did not meet targets
When Initial Advice Was Not Sufficient
The first approach for this population is structured education and counselling about the relationship between frequent acute medication use and headache chronification. When assessed at 2 months, this step is considered insufficient if it did not achieve a transition from a chronic to an episodic headache pattern, or did not reduce symptomatic medication intake to fewer than 10 days per month.
This protocol outlines the structured next step taken after that failure.
Next-Step Approach (Partial Overview)
When advice alone has not been sufficient, preventive pharmacological treatment becomes indicated — with the important prerequisite of addressing ongoing medication overuse before any new treatment is initiated. The complete selection of options, clinical decision criteria, and treatment algorithm are in the full protocol.
Clinical goal: Reduction in monthly migraine days from baseline, reassessed at approximately 12 weeks.
References
DOI: 10.1111/ene.14268
- Advice alone is an appropriate initial treatment approach in patients who overuse triptans or simple analgesics and who do not have major psychiatric comorbidity.
- Drug intake can be abruptly terminated or restricted in patients overusing simple analgesics, ergots or triptan medication.
- Topiramate, onabotulinum toxin A or a monoclonal antibody targeting CGRP or the CGRP receptor are effective in patients with chronic migraine and medication overuse.
- Topiramate should not be used in women of childbearing potential.
- In clinical practice, advice to stop overuse should be provided before starting patients on these treatments (see also PICO question 5).
- Other preventive medications such as beta-blockers, flunarizine or amitriptyline may be used, although their efficacy has not been shown in randomized, placebo-controlled trials.
- Monthly migraine days were reduced by 6.6 days after 12 weeks in 667 patients with chronic migraine, 41% of whom had medication overuse.
View source ↗